News – Page 137 – Endpoints News

Biovance debuts with €51M to lift up biotech scene in Portugal and southern Europe

11 months ago

German antibody company secures €63M for autoimmune disease program

11 months ago

Acquired biotech accuses Novartis of letting IL-15 asset 'wither on the vine'

11 months ago

Roche to reintroduce ocular implant two years after pulling it off the market

11 months ago

Gilead's HIV drug patent battle with CDC continues with government appeal

11 months ago

Lilly bests Novo Nordisk in observational study of GLP-1 drugs

11 months ago

When can pharma companies correct online misinformation? FDA explains

11 months ago

Digital health deals rallied in the first half of 2024, though funding still trails last year

11 months ago

Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows

11 months ago

HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants

11 months ago

Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii

11 months ago

Vanqua raises $45M; Aerovate to look for strategic alternatives

11 months ago

Ideaya showcases proof-of-concept data in a boost to synthetic lethality play

11 months ago

Lilly discloses its first biotech acquisition of the year, buying Morphic for $3.2B

11 months ago

With cash expected to run dry, Inventiva ramps up search for funding

11 months ago

VC firm emerges to boost Austrian biotech scene that’s ‘ready to break out’

11 months ago

In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support

11 months ago

Eli Lilly’s Alzheimer’s OK; GSK picks its mRNA bets; Megaround tally; Biosecure's shadow; and more

11 months ago

Circle Pharma raises $54M as part of Series D while macrocycles heat up

11 months ago

Innovent reworks deal with IASO; Granza raises $7M

11 months ago

UK trade group slams Novo, Novartis, Pfizer and Otsuka for code breaches

11 months ago

Avid Bio’s 2024 revenue drops; Lotte Bio breaks ground on new $3.3B site

11 months ago

Roche’s TIGIT drug tiragolumab flunks another Phase 3 lung cancer test

11 months ago

Federal judge tosses Boehringer Ingelheim's IRA lawsuit, deciding Medicare negotiations are voluntary

11 months ago

First page Previous page 134 135 136137138 139 140 Next page Last page